Key facts
- This page summarizes Robert J. Kammer's Form 4 filing for HARROW HEALTH, INC. (HROW).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 28 Jun 2021, 20:57.
Robert J. Kammer - 25 Jun 2021 Form 4 Insider Report for HARROW HEALTH, INC. (HROW)
- Reporting relationship
- Director
- Issuer ticker
- HROW
- Reported as of
- 25 Jun 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Robert Kammer
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Robert J. Kammer filed Form 4 for HARROW HEALTH, INC. (HROW) on 28 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HROW
transaction
Derivative
RSU
Award
- Transaction value
- $0
- Shares
- +9,644
- Change %
- Price
- $0.000000
- Shares after
- 9,644
- Date
- 25 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,644
- Exercise price
- $0.000000
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Restricted Stock Units were received as a compensatory award for no consideration.
Footnote F2
Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service.